The use of monoclonal antibody to tumor necrosis factor in the treatment of refractory Crohn's disease in adolescents

被引:0
|
作者
Serrano, MS [1 ]
Udall, JN [1 ]
Brown, RF [1 ]
Schmidt-Sommerfeld, E [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
989
引用
收藏
页码:168A / 168A
页数:1
相关论文
共 50 条
  • [1] Golimumab in adolescents with Crohn's disease refractory to previous tumour necrosis factor antibody
    Pichler, Judith
    Memaran, Nima
    Huber, Wolf Dietrich
    Aufricht, Christoph
    Bidmon-Fliegenschnee, Bettina
    ACTA PAEDIATRICA, 2021, 110 (02) : 661 - 667
  • [2] Tacrolimus Salvage in Anti-Tumor Necrosis Factor Antibody Treatment-Refractory Crohn's Disease
    Gerich, Mark E.
    Pardi, Darrell S.
    Bruining, David H.
    Kammer, Patricia P.
    Becker, Brenda D.
    Tremaine, William T.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) : 1107 - 1111
  • [3] Treatment of pediatric Crohn's disease (CD) with anti-tumor necrosis factor α chimeric monoclonal antibody (infliximab)
    Kugathansan, S
    Rivera, MT
    Martinez, A
    Binion, DG
    Werlin, SL
    GASTROENTEROLOGY, 1999, 116 (04) : A755 - A755
  • [4] Chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease -: Reply
    Targan, SR
    Schaible, TF
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05): : 334 - 334
  • [5] Tumor necrosis factor alpha antibody therapy in Crohn's disease
    Kupcová, V
    Príkazská, M
    Detková, M
    JOURNAL OF HEPATOLOGY, 2000, 32 : 229 - 229
  • [6] Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease
    Zaccagna, A
    Bertone, A
    Puiatti, P
    Picciotto, F
    Sprujevnik, T
    Santucci, R
    Rossini, FP
    EUROPEAN JOURNAL OF DERMATOLOGY, 2003, 13 (03) : 258 - 260
  • [7] Adalimumab, a novel anti-tumor necrosis factor-α antibody in a child with refractory Crohn's disease
    Mian, S
    Baron, H
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 41 (03): : 357 - 359
  • [8] Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-α Monoclonal Antibody Treatment for Crohn's Disease
    Matsuoka, Katsuyoshi
    Kanai, Takanori
    DIGESTION, 2013, 88 (01) : 17 - 19
  • [9] Short-term efficacy of chimeric monoclonal antibody Ca2 to tumor necrosis factor A for refractory, fistulizing Crohn's disease.
    Ardizzone, S
    Bollani, S
    Colombo, E
    Imbesi, V
    Porro, GB
    GASTROENTEROLOGY, 2000, 118 (04) : A1332 - A1332
  • [10] Use of the tumor necrosis factor-blockers for Crohn's disease
    Thomson, Alan B. R.
    Gupta, Milli
    Freeman, Hugh J.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (35) : 4823 - 4854